Finzati - Logo
NUWE logo

Nuwellis, Inc.

NUWE • Medical - Devices
$0.00
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.20M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.13Healthy liquidity · 1.71Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$1.20M
52W Range2.80 - 908.25
Beta0.17
Gross Margin61.96%
Oper. Margin-134.29%
Profit Margin-2.12%
Debt/Eq0.13
Current Ratio1.71
Quick Ratio1.08
Volume928.38K

Investment DNA

How strong this company looks for long-term investors

38
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
68/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
78/100
Why this score▼
Manageable debt level · 0.13Healthy liquidity · 1.71Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 2/16/2012
Industry: Medical - Devices
P/B i: 4.58
Debt / Equity i: 0.13
Operating Margin: -134.29%
Net Margin: -211.86%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.13
Current Ratio: 1.71
Quick Ratio: 1.08
Status: Good

Insider Transactions

Recent executive and insider activity

McDonald David
Transaction: 04/28/2026
BUY
Change
+6,744
Price
$1.16
Filing
04/29/2026
Type
BUY
Feldshon Archelle Georgiou
Transaction: 04/28/2026
BUY
Change
+6,744
Price
$1.16
Filing
04/29/2026
Type
BUY
Emerson Martin J
Transaction: 04/28/2026
BUY
Change
+6,744
Price
$1.16
Filing
04/29/2026
Type
BUY